ILLUMINATION INNOVATION TRANSFORMATION

Serial Number 97566463
733

Registration Progress

Application Filed
Aug 26, 2022
Under Examination
Jun 27, 2023
Approved for Publication
May 2, 2023
Published for Opposition
May 2, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Dec 27, 2025 164 days

Trademark Image

ILLUMINATION INNOVATION TRANSFORMATION

Basic Information

Serial Number
97566463
Filing Date
August 26, 2022
Published for Opposition
May 2, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
May 23, 2025
Application
Pending
Classes
005

Rights Holder

IMMUNOLIGHT, LLC

16
Address
1901 St. Antoine Street, 6th Floor
Detroit, MI 48226

Ownership History

IMMUNOLIGHT, LLC

Original Applicant
16
Detroit, MI

IMMUNOLIGHT, LLC

Owner at Publication
16
Detroit, MI

Legal Representation

Attorney
J. Derek Mason

USPTO Deadlines

Next Deadline
164 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
December 27, 2025
Extension Available
Until June 27, 2024

Application History

40 events
Date Code Type Description Documents
May 24, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 23, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 23, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 22, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 22, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 22, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 22, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 22, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 22, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 22, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 26, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 26, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 26, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 26, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 27, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 2, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 2, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 12, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 29, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 28, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 28, 2023 ALIE A ASSIGNED TO LIE Loading...
Mar 28, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 27, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 27, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 27, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 2, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 2, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 2, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 2, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 2, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 31, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 30, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for biological tissue regeneration; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of brain disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disease or disorders

Classification

International Classes
005